Eltrombopag
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1514 publications
Aplastic anemia developed after treatment with durvalumab
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITP.
Journal: Platelets
Published: July 28, 2026
All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia.
Journal: NEJM evidence
Published: July 28, 2026
Analysis of the efficacy and safety profile of the use of eltrombopag ethanolamine tablets in patients with cirrhotic thrombocytopenia
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: July 27, 2026
Effectiveness and Safety of Two Thrombopoietin Receptor Agonists: A Retrospective Cohort Study of Adults With Primary Immune Thrombocytopenia.
Journal: Cureus
Published: July 21, 2026
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
Journal: The New England journal of medicine
Published: July 01, 2026
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
Journal: The New England journal of medicine
Published: July 01, 2026
Nasal Mucosal Necrosis in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report and Literature Review.
Journal: Journal of clinical medicine
Published: June 23, 2026
Cost-effectiveness analysis of eltrombopag, hetrombopag and romiplostim for second-line treatment of primary immune thrombocytopenia in China.
Journal: Frontiers in medicine
Published: June 23, 2026
Real-world retrospective analysis of clinical outcomes in pediatric acquired aplastic anemia: a single-center 10-year cohort study.
Journal: Frontiers in pediatrics
Published: June 22, 2026
Last Updated: 09/19/2026